An in vitro skin explant model has been proposed for prediction of gra
ft Versus host disease and reported to be highly sensitive and specifi
c for this purpose. In this study we have re-evaluated this model in b
oth HLA full-matched BMT recipient-donor sibling pairs and also in HLA
one haplotype-matched parent-children pairs. All assessments were mad
e blindly by 3 independent observers. The predictive value of the test
for the occurrence of clinical GvHD in 14 BMT patients was found to b
e less sensitive than reported previously (correlation coefficients we
re +0.019, +0.067 and -0.061 between clinical GVHD and in vitro primed
allogeneic, primed mixed and unprimed allogeneic settings, indicating
''poor'' correlation). False positive and false negative results were
high and there were also significant discrepancies between three blin
d observations in the grading of skin changes. Weighted kappa analysis
revealed that there were ''fair'' correlations between the 3 observer
s (K=0.25). These results indicated that the skin explant model is an
unpredictable test system and there are great problems in standardizat
ion of the method.